Breast Neoplasms: all 12,820 studies

Page 11 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World StudyNot yet recruitingNCT07019272
• The MIND-BC Study: MIND Diet for Breast Cancer CognitionRecruitingNCT07018986Not applicable
• EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast CancersNot yet recruitingNCT07018505
• Cognitive Training and Exercise for Women With Breast Cancer and Cognitive ImpairmentNot yet recruitingNCT07017530Not applicable
• Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in PakistanRecruitingNCT07015944Not applicable
• ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and RadiationNot yet recruitingNCT07015853Phase 2
• Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate CancerRecruitingNCT07014618
• Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast CancerRecruitingNCT07014410Phase 2
• Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast CancerRecruitingNCT07012720Not applicable
• Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant TherapyNot yet recruitingNCT07012707
• Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBCNot yet recruitingNCT07011823Phase 2
• A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer PatientsRecruitingNCT07010939
• Utility of a Mobile Application for Young Women With Breast CancerRecruitingNCT07009093Not applicable
• Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast CancerRecruitingNCT07008976Phase 3
• Impact of Nipple Reconstruction in Mastectomized Patients Using Cross-Linked Hyaluronic Acid Injection.RecruitingNCT07008339Not applicable
• ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerRecruitingNCT07007559Phase 2
• Mediterranean Diet and Inequality in Early Breast CancerRecruitingNCT07007169Phase 2
• Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR RadiotherapyNot yet recruitingNCT07005882Phase 2
• Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast CancerNot yet recruitingNCT07005583Phase 2
• Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast CancerNot yet recruitingNCT07005557Phase 3
• Evaluation of Clinical Efficacy of Augmented Reality (AR)-Based Breast Cancer Medical Imaging Solution (SKIA-Breast) Localization Method in Breast Cancer PatientsRecruitingNCT07003841Not applicable
• A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast CancerRecruitingNCT07003074Phase 3
• Immun Checkpoint Washout in Patients With Invasive Ductal Breast CancerRecruitingNCT07003009Not applicable
• A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BCRecruitingNCT07002177Phase 1/2
• Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer SurvivorsRecruitingNCT07001241Phase 2
• The Role of Mucosal Associated Invariant t Lymphocytes in Breast CancerNot yet recruitingNCT07000396
• Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine TherapyRecruitingNCT06998108Phase 3
• Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 InhibitorNot yet recruitingNCT06996093Phase 3
• The Vanguard Study: Testing a New Way to Screen for CancerRecruitingNCT06995898Not applicable
• Breast Cancer and Chemobrain : Effects of Photobiomodulation on the Improvement of Perceived Cognitive ImpairmentRecruitingNCT06995443Not applicable
• The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast ReconstructionRecruitingNCT06995118Not applicable
• Emotional Distress in Patients With Metastatic Breast Cancer in First Line of TherapyRecruitingNCT06994377
• Acupuncture for Anxiety and DepressionNot yet recruitingNCT06994351Not applicable
• Phase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsRecruitingNCT06993844Phase 1/2
• Contrast-enhanced Mammography in Women With a Personal History of Breast Cancer and Dense Breast Tissue: Benefit?Not yet recruitingNCT06993246Not applicable
• Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant TherapyRecruitingNCT06992336Phase 2
• Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in SpainRecruitingNCT06991946
• Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker ExplorationRecruitingNCT06991790
• Photobiomodulation in Radiodermatitis in People With Breast CancerNot yet recruitingNCT06990165Not applicable
• Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast CancerRecruitingNCT06989450Not applicable
• Heart Pillow - ChemoteraphyEnrolling by invitationNCT06986213Not applicable
• Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast CancerRecruitingNCT06984250
• Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerRecruitingNCT06982521Phase 3
• Compassion, Social Support, Flexibility, and Resilience Program for Women Surviving Breast CancerEnrolling by invitationNCT06982391Not applicable
• ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and SatisfactionRecruitingNCT06981208Not applicable
• Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)RecruitingNCT06977893Phase 3
• Intra-operative Detection of Positive Margins and Lymph Nodes in Breast SurgeryRecruitingNCT06977698
• Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast CancerNot yet recruitingNCT06977542Phase 2
• Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research ProposalRecruitingNCT06977360Not applicable
• Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast CancerRecruitingNCT06976944Phase 2
• Muscle Oxygen Saturation and Functional Capacity in Breast Cancer SurvivorsNot yet recruitingNCT06976593
• Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)Not yet recruitingNCT06975644Not applicable
• SHR-A1811 and THPy in First or Second Line for HER2 Positive Advanced Breast Cancer Brain MetastasesNot yet recruitingNCT06975475Phase 2
• A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain MetastasesNot yet recruitingNCT06975462Phase 2
• A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast CancerRecruitingNCT06974929Phase 1/2
• Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DMRecruitingNCT06974604Phase 2
• ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast CancerRecruitingNCT06970912Phase 2
• Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer DetectionRecruitingNCT06970288
• To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.RecruitingNCT06970275
• QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast CancerRecruitingNCT06967103Phase 2
• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RecruitingNCT06966700Phase 3
• Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing RadiationRecruitingNCT06966388Phase 1
• Multi-center MRD Registry for Inflammatory Breast CancerRecruitingNCT06966050
• Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization StageNot yet recruitingNCT06965556Not applicable
• Auricular Acupressure for Sleep Disorder Prevention in Breast CancerNot yet recruitingNCT06964945Not applicable
• Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast CancerRecruitingNCT06964906Phase 2
• The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral NeuropathyRecruitingNCT06964802Not applicable
• Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer PatientsRecruitingNCT06962163Not applicable
• 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast CancerRecruitingNCT06961955Phase 2
• Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue ManagementRecruitingNCT06960720Not applicable
• Two Versus One Week Breast Radiotherapy (RT)RecruitingNCT06960707Phase 3
• Sustainable Implementation of the EXCEL Exercise Oncology Program Across CanadaRecruitingNCT06960291Not applicable
• Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant RadiotherapyEnrolling by invitationNCT06958445Phase 2
• Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis CancersRecruitingNCT06958224Not applicable
• Community-led Navigation to Address Disparities in Mammography Among Native American WomenRecruitingNCT06957535Not applicable
• A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid TumorsRecruitingNCT06956690Phase 1/2
• Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer PatientsRecruitingNCT06955702Not applicable
• Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBCRecruitingNCT06955156Phase 2
• A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast CancerRecruitingNCT06954961Phase 3
• Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast CancerRecruitingNCT06954831Phase 2
• Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast CancerRecruitingNCT06954480Phase 2
• MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized TrialRecruitingNCT06954337Not applicable
• Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing RadiotherapyRecruitingNCT06953245
• Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast CancerRecruitingNCT06952920Phase 3
• Effects of Two Strength Exercise Programs on Upper Limb Functionality in Breast CancerNot yet recruitingNCT06952270Not applicable
• Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical StudyNot yet recruitingNCT06950671
• HER2 Vaccine for Locally Advanced Breast CancerRecruitingNCT06949410Phase 1
• Comparison Between Erector Spinae Plane Block Versus Serratus Anterior Plane Block Regarding Analgesia Post Modified Radical MastectomyRecruitingNCT06947330Phase 3
• Single-fraction APBI for Early-stage Breast Cancer With Favorable Histological Subtypes (Breast-1F)RecruitingNCT06946238Not applicable
• Reflects the Intervention (AI Chatbot)Not yet recruitingNCT06943911Not applicable
• A Study of MT-4561 in Patients With Various Advanced Solid TumorsRecruitingNCT06943521Phase 1/2
• Breast Cancer PET/CT Imaging With 68Ga-pAKTiEnrolling by invitationNCT06943313
• A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast CancerNot yet recruitingNCT06941142Phase 1
• ERAS Protocols in Breast Conserving SurgeryRecruitingNCT06938581Not applicable
• The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer SurvivorsRecruitingNCT06938555Not applicable
• Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid DepressionRecruitingNCT06938373
• Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled TrialRecruitingNCT06938360Not applicable
• SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast TumorsNot yet recruitingNCT06937281Not applicable
• The Efficacy of Oral Cryotherapy in Preventing TROP2-ADC-Induced Oral Mucositis in Patients With Advanced Breast CancerNot yet recruitingNCT06934733Not applicable
• TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast CancerRecruitingNCT06931769

← Breast Neoplasms overview